These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Boost Infiltration and Activity of T Cells via Inhibiting Ecto-5'-nucleotidase (CD73) Immune Checkpoint to Enhance Glioblastoma Immunotherapy. Zhang H; Yang L; Han M; Han Y; Jiang Z; Zheng Q; Dong J; Wang T; Li Z ACS Nano; 2024 Aug; 18(34):23001-23013. PubMed ID: 39150454 [TBL] [Abstract][Full Text] [Related]
5. The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation. Bavaresco L; Bernardi A; Braganhol E; Cappellari AR; Rockenbach L; Farias PF; Wink MR; Delgado-Cañedo A; Battastini AM Mol Cell Biochem; 2008 Dec; 319(1-2):61-8. PubMed ID: 18636315 [TBL] [Abstract][Full Text] [Related]
6. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice. Montesinos MC; Takedachi M; Thompson LF; Wilder TF; Fernández P; Cronstein BN Arthritis Rheum; 2007 May; 56(5):1440-5. PubMed ID: 17469101 [TBL] [Abstract][Full Text] [Related]
7. Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas. Xu S; Shao QQ; Sun JT; Yang N; Xie Q; Wang DH; Huang QB; Huang B; Wang XY; Li XG; Qu X Neuro Oncol; 2013 Sep; 15(9):1160-72. PubMed ID: 23737488 [TBL] [Abstract][Full Text] [Related]
8. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. Clayton A; Al-Taei S; Webber J; Mason MD; Tabi Z J Immunol; 2011 Jul; 187(2):676-83. PubMed ID: 21677139 [TBL] [Abstract][Full Text] [Related]
9. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice. Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240 [TBL] [Abstract][Full Text] [Related]
10. The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy. Jiang X; Wu X; Xiao Y; Wang P; Zheng J; Wu X; Jin Z Front Immunol; 2023; 14():1110325. PubMed ID: 36776866 [TBL] [Abstract][Full Text] [Related]
11. Involvement of CD73 (ecto-5'-nucleotidase) in adenosine generation by human gingival fibroblasts. Hashikawa T; Takedachi M; Terakura M; Saho T; Yamada S; Thompson LF; Shimabukuro Y; Murakami S J Dent Res; 2003 Nov; 82(11):888-92. PubMed ID: 14578500 [TBL] [Abstract][Full Text] [Related]
12. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine. Kobie JJ; Shah PR; Yang L; Rebhahn JA; Fowell DJ; Mosmann TR J Immunol; 2006 Nov; 177(10):6780-6. PubMed ID: 17082591 [TBL] [Abstract][Full Text] [Related]
13. CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells. Flores-Santibáñez F; Fernández D; Meza D; Tejón G; Vargas L; Varela-Nallar L; Arredondo S; Guixé V; Rosemblatt M; Bono MR; Sauma D Immunology; 2015 Dec; 146(4):582-94. PubMed ID: 26331349 [TBL] [Abstract][Full Text] [Related]
14. Selective induction of CD73 expression in human lymphocytes by CD38 ligation: a novel pathway linking signal transducers with ecto-enzyme activities. Peola S; Borrione P; Matera L; Malavasi F; Pileri A; Massaia M J Immunol; 1996 Nov; 157(10):4354-62. PubMed ID: 8906810 [TBL] [Abstract][Full Text] [Related]
15. CD73-positive extracellular vesicles promote glioblastoma immunosuppression by inhibiting T-cell clonal expansion. Wang M; Jia J; Cui Y; Peng Y; Jiang Y Cell Death Dis; 2021 Nov; 12(11):1065. PubMed ID: 34753903 [TBL] [Abstract][Full Text] [Related]
16. Activity and expression of ecto-5'-nucleotidase/CD73 are increased during phenotype conversion of a hepatic stellate cell line. Andrade CM; Roesch GC; Wink MR; Guimarães EL; Souza LF; Jardim FR; Guaragna RM; Bernard EA; Margis R; Borojevic R; Battastini AM; Guma FC Life Sci; 2008 Jan; 82(1-2):21-9. PubMed ID: 18037449 [TBL] [Abstract][Full Text] [Related]